Comprehensive Therapy

, Volume 30, Issue 1, pp 55–69 | Cite as

Acute bronchitis: State of the art diagnosis and therapy

  • Fernando J. Martinez
Original Article


In managing acute bronchitis, pneumonia or an exacerbation of underlying chronic bronchitis should be excluded. Simple bronchitis is best treated symptomatically while an exacerbation of chronic bronchitis can be treated with antibiotics. Broad spectrum antibiotics are appropriate in selected patients.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Knutson D, Braun C. Diagnosis and management of acute bronchitis. Am Fam Phy. 2002:65:2039–44.Google Scholar
  2. 2.
    Gonzales R, Sande MA. Uncomplicated acute bronchitis. Ann Intern Med. 2000;133:981–91.PubMedGoogle Scholar
  3. 3.
    Steinman MA, Landefeld CS, Gonzales R. Predictors of broad-spectrum antibiotic prescribing for acute respiratory tract infections in adult primary care. JAMA. 2003;289:719–25.PubMedCrossRefGoogle Scholar
  4. 4.
    Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA. 1997;278:901–4.PubMedCrossRefGoogle Scholar
  5. 5.
    Cantrell R, Young AF, Martin BC. Antibiotic prescribing in ambulatory care settings for adults with colds, upper respiratory tract infections, and bronchitis. Clin Ther. 200224:170–82.PubMedCrossRefGoogle Scholar
  6. 6.
    Niederman MS, McCombs JS, Unger AN, Kumar A, Popovian R. Treatment cost of acute exacerbations of chronic bronchitis. Clin Therapeut. 1999;21:576–91.CrossRefGoogle Scholar
  7. 7.
    Hall CB, Geiman JM, Biggar R, Kotok KI, Hogan PM, Douglas Jr GR. Respiratory syncytial virus infection within families. N Engl J Med. 1976;294:414–9.PubMedCrossRefGoogle Scholar
  8. 8.
    Falsey AR, Walsh EE. Respiratory syncytial virus infection in adults. Clin Microbiol Rev. 2000;13:371–84.PubMedCrossRefGoogle Scholar
  9. 9.
    Dowell SF, Anderson LJ, Gary HEJ, Erdman DD, Plouffe JF, File Jr TM. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults. J Infect Dis. 1996;174:456–62.PubMedGoogle Scholar
  10. 10.
    Falsey AR, Cunningham CK, Barker WH, et al. Respiratory syncytial virus and influenza A infections in the hospitalized elderly. J Infect Dis. 1995;172:389–94.PubMedGoogle Scholar
  11. 11.
    Monto AS, Gravenstein S, Elliott M, Colopy M, Schweinle J. Clinical signs and symptoms predicting influenza infection. Arch Intern Med. 2000;160:3243–7.PubMedCrossRefGoogle Scholar
  12. 12.
    Macfarlane JT, Colville A, Guion A, Macfarlane RM, Rose EH. Prospective study of aetiology and outcome of adult lower-respiratory-tract infections in the community. Lancet. 1993;341:511–514.PubMedCrossRefGoogle Scholar
  13. 13.
    Macfarlane J, Holmes W, Gard P, et al., Prospective study of the incidence, aetiology and outcome of adult lower respiratory tract illness in the community. Thorax. 2001;56:109–14.PubMedCrossRefGoogle Scholar
  14. 14.
    Hament JM, Kimpen JLL, Fleer A, Wolfs TFW. Respiratory viral infection predisposing for bacterial disease: A concise review. FEMS Immunol Med Microbiol. 1999;26:189–95.PubMedCrossRefGoogle Scholar
  15. 15.
    Hahn DL, Azenabor AA, Beatty WL, Byrne GI. Chlamydia pneumoniae as a respiratory pathogen. Front Biosci. 2002;7:66–76.Google Scholar
  16. 16.
    von Konig CHW, Halperin S, Riffelmann M, Guiso N. Pertussis of adults and infants. Lancet Inf Dis. 2002;2:744–50.CrossRefGoogle Scholar
  17. 17.
    Anonymous. Resurgence of pertussis United States, 1993. MMWR Morb Mortal Wkly Rep. 1993;42:952-3/959-60.Google Scholar
  18. 18.
    Metlay JP, Kapoor WN, Fine JM. Does this patient have community-acquired pneumonia? diagnosing pneumonia by history and physical examination. JAMA. 1997;278:1440–5.PubMedCrossRefGoogle Scholar
  19. 19.
    Metlay JP, Fine MJ. Testing strategies in the initial management of patients with community-acquired pneumonia. Ann Intern Med. 2003;138:109–18.PubMedGoogle Scholar
  20. 20.
    Ruiz M, Arosio C, Salman P, Bauer TT, Torres A. Diagnosis of pneumonia and monitoring of infection eradication. Drugs. 2000;60:1289–302.PubMedCrossRefGoogle Scholar
  21. 21.
    McFadden JP, Price RC, Eastwood HD, Briggs RS. Raised respiratory rate in elderly patients: A valuable physical sign. Br Med J. 1982;284:626–7.Google Scholar
  22. 22.
    Metlay JP, Schulz R, Li YH, et al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med. 1997;157:1453–9.PubMedCrossRefGoogle Scholar
  23. 23.
    Seppa Y, Bloigu A, Honkanen PO, Miettinen L, Syrjala H. Severity assessment of lower respiratory tract infection in elderly patients in primary care. Arch Intern Med. 2001;161:2709–13.PubMedCrossRefGoogle Scholar
  24. 24.
    Wipf JE, Lipsky BJ, Hirschmann JV, et al. Diagnosing pneumonia by physical examination. Relevant or relic? Arch Intern Med. 1999;59:1082–7.CrossRefGoogle Scholar
  25. 25.
    Dumyati G, Falsey AR. Antivirals for influenza. What is their role in the older patient? Drugs Aging. 2002;19:777–86.PubMedCrossRefGoogle Scholar
  26. 26.
    Bloivin G, Hardy I, Tellier G, Mazaide J. Predicting influenza infections during epidemics with use of a clinical case definition. Clin Inf Dis. 2003;31:1166–9.CrossRefGoogle Scholar
  27. 27.
    Walsh EE, Cox C, Falsey AR. Clinical features of influenza A virus infection in older hospitalized persons. J Am Geriatr Soc. 2002;50:1498–503.PubMedCrossRefGoogle Scholar
  28. 28.
    Neuzil KM, O’Connor TZ, Gorse GJ, Nichol KL. Recognizing influenza in older patients with chronic obstructive pulmonary disease who have received influenza vaccine. Clin Inf Dis. 2003;36:169–74.CrossRefGoogle Scholar
  29. 29.
    Irwin RS, Boulet LP, Cloutier MM, et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest. 1998;114:133S-81S.PubMedGoogle Scholar
  30. 30.
    Williamson Jr HA. Pulmonary function tests in acute bronchitis: Evidence for reversible airflow obstruction. J Fam Pract. 1987;3:251–6.Google Scholar
  31. 31.
    Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: Clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med. 1990;84:377–85.PubMedGoogle Scholar
  32. 32.
    Jonsson JS, Gislason T, Gislason D, Sigurdsson JA. Acute bronchitis and clinical outcome three years later: Prospective cohort study. BMJ. 1998;317:1433.PubMedGoogle Scholar
  33. 33.
    Metlay JP, Stafford RS, Singer DE. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med. 1998;158:1813–8.PubMedCrossRefGoogle Scholar
  34. 34.
    Dosh SA, Hickner J, Mainous III AG, Ebell MH. Predictors of antibiotic prescribing for nonspecific upper respiratory infections, acute bronchitis, and acute sinusitis: An UPRNet study. J Fam Pract. 2000;49:407–14.PubMedGoogle Scholar
  35. 35.
    Hueston WJ, Hopper JE, Dacus EN, Mainous III AG. Why are antibiotics prescribed for patients with acute bronchitis? A postintervention analysis. J Am Board Fam Pract. 2000;13:398–402.PubMedGoogle Scholar
  36. 36.
    Linder JA, Sim I. Antibiotic treatment of acute bronchitis in smokers. A systematic review. J Gen Intern Med. 2002;17:230–4.PubMedCrossRefGoogle Scholar
  37. 37.
    Gonzales R, Bartlett JG, Besser RE, et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: Background. Ann Emerg Med. 2001;37:720–7.PubMedCrossRefGoogle Scholar
  38. 38.
    Macfarlane J, Holmes W, Gard P, Thornhill D, Macfarlane R, Hubbard R. Reducing antibiotic use for acute bronchitis in primary care: blinded randomised controlled trial of patient information leaflet. BMJ. 2002;324:1–6.Google Scholar
  39. 39.
    Gonzales R, Steiner JF, Lum A, Barrett Jr PH. Decreasing antibiotic use in ambulatory practice. Impact of a multidimensional intervention on the treatment of uncomplicated acute bronchitis in adults. JAMA. 1999;281:1512–9.PubMedCrossRefGoogle Scholar
  40. 40.
    Gonzales R, Steiner JF, Maselli J, Lum A, Barrett PH. Impact of reducing antibiotic prescribing for acute bronchitis on patient satisfaction. Eff Clin Pract. 2001;4:105–11.PubMedGoogle Scholar
  41. 41.
    Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract. 1991;33:476–80.PubMedGoogle Scholar
  42. 42.
    Smucny JJ, Flynn CA, Becker LA, Glazier RH. Are β2-agonists effective treatment for acute bronchitis or acute cough in patients without underlying pulmonary disease? A systematic review. J Fam Pract. 2001;50:945–51.PubMedGoogle Scholar
  43. 43.
    Melbye H, Aasebo U, Straume B. Symptomatic effect of inhaled fenoterol in acute bronchitis: A placebo-controlled double-blind study. Fam Pract. 1991;8:216–22.PubMedCrossRefGoogle Scholar
  44. 44.
    Sethi S, Murphy TF. Bacterial infection in chronic obstructive pulmonary disease in 2000: A state-of-the-art review. Clin Microbiol Rev. 2001;14:336–63.PubMedCrossRefGoogle Scholar
  45. 45.
    White AJ, Gompertz S, Stockley RA. Chronic obstructive pulmonary disease 6: The etiology of exacerbations of chronic obstructive pulmonary disease. Thorax. 2003;58:73–80.PubMedCrossRefGoogle Scholar
  46. 46.
    Miravitlles M. Exacerbations of chronic obstructive pulmonary disease: When are bacteria important? Eur Respir J. 2002;20(Suppl 36):9S-19S.CrossRefGoogle Scholar
  47. 47.
    Wilson R. Bacteria, antibiotics and COPD. Eur Respir J. 2001;17:995–1007.PubMedCrossRefGoogle Scholar
  48. 48.
    Monso E, Ruiz J, Rosell A, et al. Bacterial infection in chronic obstructive pulmonary disease: A study of stable and exacerbated outpatients using the protected specimen brush. Am J Respir Crit Care Med. 1995;152:1316–20.PubMedGoogle Scholar
  49. 49.
    Fagon JY, Chastre J, Trouillet JL, et al. Characterization of distal bronchial microflora during acute exacerbation of chronic bronchitis. Use of the protected specimen brush technique in 54 mechanically ventilated patients. Am Rev Respir Dis. 1990;142:1004–8.PubMedGoogle Scholar
  50. 50.
    Soler N, Torres A, Ewig S, et al. Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation. Am J Respir Crit Care Med. 1998;157:1498–1505.PubMedGoogle Scholar
  51. 51.
    Pela R, Marchesani F, Agostinelli C, et al. Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: A bronchoscopic investigation. Monaldi Arch Chest Dis. 1998;53:262–7.PubMedGoogle Scholar
  52. 52.
    Zalacain R, Sobradillo V, Amilibia J, et al. Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease. Eur Respir J. 1999;13:343–8.PubMedCrossRefGoogle Scholar
  53. 53.
    Bandi V, Apicella MA, Mason E, et al. Nontypeable Haemophilus influenzae in the lower respiratory tract of patients with chronic bronchitis. Am J Respir Crit Care Med. 2001;164:2114–9.PubMedGoogle Scholar
  54. 54.
    Groeneveld K, Eijk PP, van Alphen L, Jansen HM, Zanen HC. Haemophilus influenzae infections in patients with chronic obstructive pulmonary disease despite specific antibodies in serum and sputum. Am Rev Respir Dis. 1990;141:1316–21.PubMedGoogle Scholar
  55. 55.
    Yi K, Sethi S, Murphy TF. Human immune response to nontypable Haemophilus influenzae in chronic bronchitis. J Infect Dis. 1997;176:1247–52.PubMedGoogle Scholar
  56. 56.
    Patel IS, Seemungal TAR, Wilks M, Lloyd-Owen SJ, Donaldson GC, Wedzicha JA. Relationship between bacterial colonisation and the frequency, character, and severity of COPD exacerbations. Thorax. 2002;57:759–64.PubMedCrossRefGoogle Scholar
  57. 57.
    Wilkinson TMA, Patel IS, Wilks M, Donaldson GC, Wedzicha JA. Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2003;167:1090–5.PubMedCrossRefGoogle Scholar
  58. 58.
    Sethi S, Evans N, Grant BJB, Murphy TF. New strains of bacteria and exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;347:465–71.PubMedCrossRefGoogle Scholar
  59. 59.
    Stockley RA, O’Brien C, Pye A, Hill SL. Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. Chest. 2000;117:1638–45.PubMedCrossRefGoogle Scholar
  60. 60.
    Aaron SD, Angel JB, Lunua M, et al. Granulocyte inflammatory markers and airway infection during acute exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;163:349–55.PubMedGoogle Scholar
  61. 61.
    Saetta M, Di Stefano A, Maestrelli P, et al. Airway eosinophilia in chronic bronchitis during exacerbations. Am J Respir Crit Care Med. 1994;150:1646–52.PubMedGoogle Scholar
  62. 62.
    Balbi B, Bason C, Balleari E, et al. Increased bronchoalveolar granulocytes and granulocyte/macrophage colony-stimulating factor during exacerbations of chronic bronchitis. Eur Respir J. 1997;10:846–50.PubMedGoogle Scholar
  63. 63.
    Bhowmik A, Seemungal TAR, Sapsford RJ, Wedzicha JA. Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations. Thorax. 2000;55:114–20.PubMedCrossRefGoogle Scholar
  64. 64.
    Gompertz S, O’Brien C, Bayley DL, Hill SL, Stockley RA. Changes in bronchial inflammation during acute exacerbations of chronic bronchitis. Eur Respir J. 2001;17:1112–9.PubMedCrossRefGoogle Scholar
  65. 65.
    Hill AT, Campbell EJ, Hill SL, Bayley DL, Stockley RA. Association between airway bacterial load and markers of airway inflammation in patients with stable chronic bronchitis. Am J Med. 2000;109:288–95.PubMedCrossRefGoogle Scholar
  66. 66.
    Soler N, Ewig S, Torres A, Filella X, Gonzalez J, Zaubet A. Airway inflammation and bronchial microbial patterns in patients with stable chronic obstructive pulmonary disease. Eur Respir J. 1999;14:1015–22.PubMedCrossRefGoogle Scholar
  67. 67.
    Bresser P, Out TA, van Alphen L, Jansen HM, Lutter R. Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic Haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;162:947–52.PubMedGoogle Scholar
  68. 68.
    Sethi S, Muscarella K, Evans N, Klingman KL, Grant BJB, Murphy TF. Airway inflammation and etiology of acute exacerbations of chronic bronchitis. Chest. 2000;118: 1557–65.PubMedCrossRefGoogle Scholar
  69. 69.
    Bresser P, van Alphen L, Habets F J, et al. Persisting Haemophilus influenzae strains induce, lower levels of interleukin-6 and interleukin-8 in H292 lung epithelial cells than nonpersisting strains. Eur Respir J. 1997;10:2319–26.PubMedCrossRefGoogle Scholar
  70. 70.
    Hill AT, Campbell EJ, Bayley DL, Hill SL, Stockley RA. Evidence for excessive bronchial inflammation during an acute exacerbation of chronic obstructive pulmonary disease in patients with α1-antitrypsin deficiency (PiZ). Am J Respir Crit Care Med. 1999;160:1968–75.PubMedGoogle Scholar
  71. 71.
    Miravitlles M, Espinosa C, Fernandez-Laso E, et al., and Study Group of Bacterial Infection in COPD. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest. 1999;116:40–6.PubMedCrossRefGoogle Scholar
  72. 72.
    Eller J, Ede A, Schaberg T, Niederman M, Mauch H, Lode H. Infective exacerbations of chronic obstructive pulmonary disease. Relation between bacteriologic etiology and lung function. Chest. 1998;113:1542–8.PubMedGoogle Scholar
  73. 73.
    O’Brien C, Guest PJ, Hill SL, Stockley RA. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55:635–42.PubMedCrossRefGoogle Scholar
  74. 74.
    Blasi F, Damato S, Cosentini R, et al. Group Chlamydia InterAction with COPD (CIAC) Study. Chlamydia pneumoniae and chronic bronchitis: Association with severity and bacterial clearance following treatment. Thorax. 2002;57: 672–6.PubMedCrossRefGoogle Scholar
  75. 75.
    Lieberman D, Ben-Yaakov M, Lazarovich Z, Ohana B, Boldur I. Chlamydia pneumoniae infection in acute exacerbations of chronic obstructive pulmonary disease: Analysis of 250 hospitalizations. Eur J Clin Microbiol Infect Dis. 2001;20: 698–704.PubMedCrossRefGoogle Scholar
  76. 76.
    Karnak D, Beng-sun S, Beder S, Kayacan O, Chlamydia pneumoniae infection and acute exacerbation of chronic obstructive pulmonary disease (COPD). Respir Med. 2001;95:811–6.PubMedCrossRefGoogle Scholar
  77. 77.
    Mogulkoc N, Karakurt S, Isalska B, et al. Acute purulent exacerbation of chronic obstructive pulmonary disease and Chlamydia pneumoniae infection. Am J Respir Crit Care Med. 1999;160:349–53.PubMedGoogle Scholar
  78. 78.
    Wedzicha JA. Exacerbations. Etiology and pathophysiologic mechanisms. Chest. 2002;121:136S-41S.PubMedCrossRefGoogle Scholar
  79. 79.
    Seemungal T, Harper-Owen R, Bhowmik A, et al. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001;164:1618–23.PubMedGoogle Scholar
  80. 80.
    Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J. 2000;16:677–83.PubMedCrossRefGoogle Scholar
  81. 81.
    Seemungal TA, Wedzicha JA. Viral infections in obstructive airway disease. Curr Opin Pulm Med. 2003;9:111–6.PubMedCrossRefGoogle Scholar
  82. 82.
    American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1995;152:S77-S120.Google Scholar
  83. 83.
    Sohy C, Pilette C, Niederman MS, Sibile Y. Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still-needed? Eur Respir J. 2002;19: 966–75.PubMedCrossRefGoogle Scholar
  84. 84.
    Rodrigues-Roisin R. Toward a consensus definition for COPD exacerbations. Chest. 2000;117:398S-401S.CrossRefGoogle Scholar
  85. 85.
    Seemungal TAR, Donaldson GC, Bhowmik A, Jeffries DJ, Wedzicha JA. Time course and recovery of exacerbations in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000;161:1608–13.PubMedGoogle Scholar
  86. 86.
    Emerman CL, Cydulka RK. Evaluation of high-yield criteria for chest radiography in acute exacerbation of chronic obstructive pulmonary disease. Ann Emerg Med. 1993;22: 780–4.Google Scholar
  87. 87.
    Sherman S, Skoney JA, Ravikrishnan KP. Routine chest radiographs in exacerbations of chronic obstructive pulmonary disease. Diagnostic value. Arch Intern Med. 1989; 149:2493–6.PubMedCrossRefGoogle Scholar
  88. 88.
    Tsai TW, Gallagher EJ, Lombardi G, Gennis P, Carter W. Guidelines for the selective ordering of admission chest radiography in adult obstructive airway disease. Ann Emerg Med. 1993;22:1854–8.PubMedCrossRefGoogle Scholar
  89. 89.
    Bach PB, Brown C, Gelfand SE, McCroy DC. Management of acute exacerbations of chronic obstructive pulmonary disease: A summary and appraisal of published evidence. Ann Intern Med. 2001;134:600–20.PubMedGoogle Scholar
  90. 90.
    Snow V, Lascher S, Mottur-Pielson C. Evidence base for management of acute exacerbations of chronic obstructive pulmonary disease. Ann Intern Med. 2001;134:595–9.PubMedGoogle Scholar
  91. 91.
    Saint S, Bent S, Vittinghoff E, Grady D. Antibiotics in chronic obstructive pulmonary disease exacerbations. A metaanalysis. JAMA. 1995;273:957–60.PubMedCrossRefGoogle Scholar
  92. 92.
    Nouira S, Marghli S, Belghith M, Besbes L, Elatrous S, Abrough F. Once daily oral ofloxacin in chronic obstructive pulmonary disease exacerbation, requiring mechanical ventilation: A randomised placebo-controlled trial. Lancet 2001; 358:2020–5.PubMedCrossRefGoogle Scholar
  93. 93.
    Allegra L, Blasi F, de Bernardi B, Cosentini R, Tarsia P. Antibiotic treatment and baseline severity or disease in acute exacerbations of chronic bronchitis: A re-evaluation of previously published data of a placebo-controlled randomized study. Pulm Pharmaco Therapeut. 2001;14:149–55.CrossRefGoogle Scholar
  94. 94.
    Anthonisen N, Manfreda J, Warren C, Hersfield E, Harding G, Nelson N. Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease. Ann Int Med. 1987;106:196–204.PubMedGoogle Scholar
  95. 95.
    Adams SG, Melo J, Luther M, Anzueto A. Antibiotics are associated with lower relapse rates in outpatients with acute exacerbations of COPD. Chest. 2000;117:1345–52.PubMedCrossRefGoogle Scholar
  96. 96.
    Niroumand M, Grossman R. Airway infection. Infect Dis Clin N Am. 1998;12:671–88.CrossRefGoogle Scholar
  97. 97.
    Miravitlles M, Murio C., Guerrero T, Factors associated with relapse after ambulatory treatment of acute exacerbations of chronic bronchitis. DAFNE Study Group. Eur Respir J. 2001;17:928–33.PubMedCrossRefGoogle Scholar
  98. 98.
    Seemungal TAR, Donaldson GC, Paul EA, Bestall JC, Jeffries DJ, Wedzicha JA. Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 1998;157:1418–22.PubMedGoogle Scholar
  99. 99.
    Saint S, Flaherty KR, Abrahamse P, Martinez FJ, Fendrick AM. Acute exacerbations of chronic bronchitis: Disease-specific issues that influence the cost-effectiveness of antimicrobial therapy. Clin Ther. 2001;23:499–512.PubMedCrossRefGoogle Scholar
  100. 100.
    Ball P, Harris J, Lowson D, Tillotson G, Wilson R. Acute infective exacerbations of chronic bronchitis. Q J Med. 1995; 88:61–8.Google Scholar
  101. 101.
    Sethi S. Etiology and management of infection in chronic obstructive pulmonary disease. Clin Pulm Med. 1999;6:327–32.Google Scholar
  102. 102.
    Anzueto AR. Risk stratification in acute exacerbations of chronic bronchitis: When and how to treat. Consultant. 2002;41(Suppl 12):S5–12.Google Scholar
  103. 103.
    Flaherty KR, Saint S, Fendrick AM, Martinez FJ. The spectrum of acute bronchitis: Using baseline factors to guide empirical therapy. Postgrad Med. 2001;109:39–47.PubMedGoogle Scholar
  104. 104.
    Niederman MS. Antimicrobial therapy for acute exacerbations of chronic bronchitis: A critical path and consensus. Consultant. 2002;42(Suppl 12):S39–44.Google Scholar
  105. 105.
    Dewan NA, Rafique S, Kanwar B, et al. Acute exacerbation of COPD: Factors associated with poor treatment outcome. Chest. 2000;117:662–71.PubMedCrossRefGoogle Scholar
  106. 106.
    Shah PM, Maesen FPV, Domann A, Vetter N, Fiss E, Wesch R. Levofloxacin versus cefuroxime axetil in the treatment of acute exacerbation of chronic bronchitis: Results of a randomized, double-blind study. J Antimicrob Chemother. 1999; 43:529–39.PubMedCrossRefGoogle Scholar
  107. 107.
    Wilson R, Kubin R, Ballin I, et al. Five day moxifloxacin therapy compared with 7 day clarithromycin therapy for the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother. 1999;44:501–13.PubMedCrossRefGoogle Scholar
  108. 108.
    Martinez FJ. The impact of antimicrobial selection on AECB: Resistance patterns of common respiratory pathogens. Consultant. 2002;42(Suppl 12):S33–8.Google Scholar
  109. 109.
    Doern GV. Antimicrobial use and the emergency of antimicrobial resistance with Streptococcus pneumoniae in the United States. Clin Inf Dis. 2001;33(Suppl 3):S187–92.CrossRefGoogle Scholar
  110. 110.
    Seaton RA, Steinke DT, Phillips G, MacDonald T, Davey PG. Community antibiotic therapy, hospitialization and subsequent respiratory tract isolation of Haemophilus influenzae resistance to amoxycillin: A nested case-control study. J Antimicrob Chemother. 2000;46:307–9.PubMedCrossRefGoogle Scholar
  111. 111.
    Thornsberry C, Sahm DF, Kelly LJ, et al. Regional trends in antimicrobial resistance among clinical isolates of Streptococcus pneumomiae, Haemophilus influenzae, and Moraxella catarrhalis in the United States: Results from the TRUST surveillance program, 1999–2000. Clin Inf Dis. 2002;34(Suppl 1):S4-S16.CrossRefGoogle Scholar
  112. 112.
    Lynch III JP, Martinez FJ. Clinical relevance of macrolide-resistant Streptococcus pneumoniae for community acquired pneumonia. Clin Inf Dis. 2002;34(Suppl 1):S27–46.CrossRefGoogle Scholar
  113. 113.
    Hyde TB, Gay K, Stephens DS, et al. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA. 2001;285:1857–62.CrossRefGoogle Scholar
  114. 114.
    Blondeau JM. A review or the comparative in-vitro activities of 12 antimicrobial agents, with a focus on five new ‘respiratory quinolones’. J Antimicrob Chemother. 1999;43(Suppl B):1–11.PubMedCrossRefGoogle Scholar
  115. 115.
    Thomson KS, Chartrand SA, Sanders CC, Block SL. In-vitro activity of levofloxacin against Streptococcus pneumoniae with various levels of penicillin resistance. J Antimicrob Chemother. 1999;43(Suppl C):15–9.PubMedCrossRefGoogle Scholar
  116. 116.
    Ho PL, Yung RWH, Tsang DNC, et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: Results of a Hong Kong multicenter study in 2000. J Antimicrob Chemother. 2001;48:659–65.PubMedCrossRefGoogle Scholar
  117. 117.
    Chen DK, McGeer A, De Azavedo JC, Low DE, Network The Canadian Bacterial Surveillance. Decreased susceptibility of Streptococcus pneumoniae to fluoroquinolones in Canada. N Engl J Med. 1999;341:233–9.PubMedCrossRefGoogle Scholar
  118. 118.
    Brueggemann AB, Coffman SL, Rhomberg P, et al. Fluoquinolone resistance in Streptococcus pneumoniae in United States since 1994–1995. Antimicrob Agent Chemother. 2002; 46:680–8.CrossRefGoogle Scholar
  119. 119.
    Daily P, Gelling L, Rothrock G, et al. Resistance of Streptococcus pneumoniae to fluoroquinolones—United States, 1995–1999. MMWR Morb Mortal Wkly Rep. 2001;50:800–4.Google Scholar
  120. 120.
    Ho PL, Tse WS, Tsang KWT, et al. Risk factors for acquisition of levofloxacin-resistance Streptococcus pneumoniae: A case-control study. Clin Inf Dis. 2001;32:701–7.CrossRefGoogle Scholar
  121. 121.
    Doern GV, Jones RN, Pfaller MA, Kugler K, The SENTRY Participants Group. Haemophilus influenzae and Moraxella catarrhalis from patients with community-acquired respiratory tract infections: Antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program (United States and Canada, 1997). J Antimicrob Chemother. Antimicrob Agent Chemother. 1999;43:385–9.Google Scholar
  122. 122.
    Richter SS, Brueggemann AB, Huynh HK, et al. A 1997–1998 national surveillance study: Moraxella catarrhalis and Haemophilus influenzae antimicrobial resistance in 34 US insitutions. Int J Antimicrob Agent. 1999;13:99–107.CrossRefGoogle Scholar
  123. 123.
    Zhanel GG, Karlowsky JA, Low DE, Hoban DJ. Antibiotic resistance in respiratory tract isolates of Haemophilus influenzae and Moraxella catarrhalis collected from across Canada in 1997–1998. J Antimicrob Chemother. 2000;45:655–62.PubMedCrossRefGoogle Scholar
  124. 124.
    Murphy TF, Sethi S, Klingman KL, Brueggemann AB, Doern GV. Simultaneous respiratory tract colonization by multiple strains of nontypeable Haemophilus influenzae in chronic obstructive pulmonary disease: Implications for antibiotic therapy. J Infect Dis. 1999;180:404–9.PubMedCrossRefGoogle Scholar
  125. 125.
    Verduin CM, Hol C, Fleer A, van Belkum A. Moraxella catarrhalis: From emerging to established pathogen. Clin Microbial Rev. 2002;15:125–44.CrossRefGoogle Scholar
  126. 126.
    Pechere JC, Lacey L. Optimizing economic outcomes in antibiotic therapy of patients with acute bacterial exacerbations of chronic bronchitis. J Antimicrob Chemother. 2000;45: 19–24.PubMedCrossRefGoogle Scholar
  127. 127.
    Madaras-Kelly KJ, Magdanz SB, Johnson CK, Jue SG. Clinical outcomes of ambulatory acute exacerbations of chronic bronchitis with older versus newer antimicrobials. Ann Pharmacother. 2002;36:975–80.PubMedCrossRefGoogle Scholar
  128. 128.
    Wilson R, Schentag JJ, Ball P, Mandell L. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes. Clin Ther. 2002;24:639–52.PubMedCrossRefGoogle Scholar
  129. 129.
    Weiss K, Restieri C, Gauthier R, et al. A nosocomial outbreak of fluoroquinolone-resistant Streptococcus pneumoniae. Clin Inf Dis. 2001;33:517–22.CrossRefGoogle Scholar
  130. 130.
    DeAbate CA, Russell M, McElvaine P, et al. Safety and efficacy of oral levofloxacin versus cefuroxime axetil in acute bacterial exacerbation of chronic bronchitis. Respir Care. 1997;42:206–13.Google Scholar
  131. 131.
    Habib MP, Gentry LO, Rodriguez-Gomez G, et al. Multicenter, randomized study comparing efficacy and safety of oral levofloxacin and cefaclor in treatment of acute bacterial exacerbations of chronic bronchitis. Infect Dis Clin Pract. 1998;7:101–9.CrossRefGoogle Scholar
  132. 132.
    Anzuelo A, Niederman MS, Tillotson GS, Bronchitis Study Group. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: Ciprofloxacin 750 mg bid versus clarithromycin 500 mg bid. Clin Ther. 1998;20:835–50.Google Scholar
  133. 133.
    Chodosh S, Schreurs A, Siami G, et al., and Group Bronchitis Study. Efficacy of oral ciprofloxacin vs clarithromycin for treatment of acute bacterial exacerbations of chronic bronchitis. Clin Inf Dis. 1998;27:730–8.Google Scholar
  134. 134.
    Grossman R, Mukherjee J, Vaughan D, et al. A 1-year community-based health economic study of ciprofloxacin vs usual antibiotic treatment in acute exacerbations of chronic bronchitis. The Canadian Ciprofloxacin Health Economic Study Group. Chest. 1998;113:131–41.PubMedGoogle Scholar
  135. 135.
    Torrance G, Walker V, Grossman R, et al. Economic evaluation of ciprofloxacin compared with usual antibacterial care for the treatment of acute exacerbations of chronic bronchitis in patients followed for 1 year. Pharmacoeconomics. 1999; 16:499–520.PubMedCrossRefGoogle Scholar
  136. 136.
    Destache CJ, Dewan N, O’Donohue WJ, Campbell JC, Angelillo VA. Clinical and economic considerations in the treatment of acute exacerbations of chronic bronchitis. J Antimicrob Chemother. 1999;43(Suppl A):107–113.PubMedCrossRefGoogle Scholar
  137. 137.
    Stoller JK. Acute exacerbations of chronic obstructive pulmonary disease. N Engl J Med. 2002;346:988–94.PubMedCrossRefGoogle Scholar
  138. 138.
    McCroy DC, Brown C, Gelfand SE, Bach PB. Management of exacerbations of COPD: A summary and appraisal of the published evidence. Chest. 2001;119:1190–209.CrossRefGoogle Scholar
  139. 139.
    Singh JM, Palda VA, Stanbrook MB, Chapman KR. Corticosteroid therapy for patients with acute exacerbations of chronic obstructive pulmonary disease. A systematic review. Arch Intern Med. 2002;162:2527–36.PubMedCrossRefGoogle Scholar
  140. 140.
    Niewoehner DE, Erbland ML, Deupree RH, et al., and Department of Veterans Affairs Cooperative Study Group. Effect of systemic glucocorticoids on exacerbationsis of chronic obstructive pulmonary disease. N Engl J Med. 1999; 340:1941–7.PubMedCrossRefGoogle Scholar
  141. 141.
    Sayner A, Aytemur AZ, Cirit M, Unsal I. Systemic glucocorticoids in severe exacerbations of COPD. Chest. 2001;119: 726–30.CrossRefGoogle Scholar
  142. 142.
    Davies L, Nisar M, Pearson MG, Costello RW, Earis JE, Calverley PMA. Oral corticosteroid trials in the management of stable chronic obstructive pulmonary disease. Q J Med. 1999;92:395–400.Google Scholar
  143. 143.
    Maltais F, Ostinelli J, Bourbeau J, et al. Comparison of nebulized budesonide and oral prednisolone with placebo in the treatment of acute exacerbations of chronic obstructive pulmonary disease: A randomized controlled trial. Am J Respir Crit Care Med. 2002;165:698–703.PubMedGoogle Scholar
  144. 144.
    Sethi S. Infectious exacerbations of chronic bronchitis: diagnosis and management. J Antimicrob Chemother. 1999;43: (Suppl A):97–105.PubMedCrossRefGoogle Scholar
  145. 145.
    Dere WH. Acute bronchitis: Results of U.S. and European trials of antibiotic therapy. Am J Med. 1992;92 (Suppl 6A): 53S-7S.PubMedCrossRefGoogle Scholar
  146. 146.
    Jonsson JS, Sigurdsson JA, Kristinsson KG, Guthnadottir M, Magnusson S. Acute bronchitis in adults. How close do we come to its aetiology in general practice? Scand J Prim Health Care. 1997;15:156–60.PubMedCrossRefGoogle Scholar
  147. 147.
    Ball P. Epidemiology and treatment of chronic bronchitis and its exacerbations. Chest. 1995;108:43S-52S.PubMedGoogle Scholar
  148. 148.
    Gwaltney Jr JM. Acute bronchitis. In: G. Mandell, J. Bennett and R. Dolin, editors. Mandell: Principles and Practice of Infectious Disease, 5th ed. Philadelphia; Churchill Livingstone, 2000:703–6.Google Scholar
  149. 149.
    Kaiser L, Lew D, Hirschel B, et al. Effects of antibiotic, treatment in the subset of common-cold patients who have bacteria in nasopharyngeal secretions. Lancet. 1996;347:1507–10.PubMedCrossRefGoogle Scholar
  150. 150.
    Falck G, Heyman L, Gnarpe J, Gnarpe H. Chlamydia Pneumoniae (TWAR): A common agent in acute bronchitis. Scand J Infect Dis. 1994;26:179–87.PubMedGoogle Scholar
  151. 151.
    Buscho RO, Saxtan D, Shultz PS, Finch E, Mufson MA. Infections with viruses and Mycoplasma pneumoniae during exacerbations of chronic bronchitis. J Infect Dis. 1978;137:377–83.PubMedGoogle Scholar
  152. 152.
    Smith CB, Goldern CA, Kanner RE, Renzetti AD. Association of viral and Mycoplasma pneumoniae infections with acute respiratory illness in patients with chronic obstructive pulmonary disease. Am Rev Respir Dis. 1980;121:225–32.PubMedGoogle Scholar
  153. 153.
    Herwaldt LA. Pertussis in adults: What physicians need to know. Arch Intern Med. 1991;151:1510–2.PubMedCrossRefGoogle Scholar
  154. 154.
    Falsey AR, McCann RM, Hall WJ, et al. The “common cold” in frail older persons: Impact of rhinovirus and coronavirus in a senior daycare center. JAGS. 1997;45:706–11.Google Scholar
  155. 155.
    Hendley JO, Fishburne HB, Swaltney JM. Coronavirus infections in working adults: Eight-year study with 229 E and OC 43. Am Rev Respir Dis. 1972;105:805–11.PubMedGoogle Scholar
  156. 156.
    Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2000; 162:167–73.PubMedGoogle Scholar
  157. 157.
    Rhode G, Wiethege A, Borg I, et al. Respiratory viruses in exacerbations of chronic obstructive pulmonary disease requiring hospitalisation: A case-control study. Thorax. 2003; 58:37–42.CrossRefGoogle Scholar
  158. 158.
    Seemungal TA, Wedzicha JA, MacCallum PK, Johnston SL, Lambert PA. Chlamydia pneumoniae and COPD exacerbation. Thorax. 2002;57:1087–8; author reply 1088–9.PubMedCrossRefGoogle Scholar
  159. 159.
    Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. BMJ. 1998;316:906–10.PubMedGoogle Scholar
  160. 160.
    Smucny JJ, Becker LA, Glazier RH, McIsaac, W. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract. 1998;47:453–60.PubMedGoogle Scholar
  161. 161.
    Bent S, Saint S, Vittinghoff E, Grady D. Antibiotics in acute bronchitis: A metal-analysis. Am J Med. 1999;07:62–7.CrossRefGoogle Scholar
  162. 162.
    Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: A randomised, double-blind, controlled trial. Lancet. 2002;359; 1648–54.PubMedCrossRefGoogle Scholar
  163. 163.
    Lode H. Respiratory tract infections: When is antibiotic therapy indicated? Clin Ther. 1991;13:149–56.PubMedGoogle Scholar
  164. 164.
    Hueston W J. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract. 1994;39.Google Scholar
  165. 165.
    Grossman R. Guidelines for the treatment of acute exacerbations of chronic bronchitis. Chest. 1997;112(Suppl 6): 311S-3S.Google Scholar
  166. 166.
    Wilson R. Outcome predictors in bronchitis. Chest. 1995;106 (Suppl):53S-57S.Google Scholar
  167. 167.
    Adams SG, Anzueto A. Antibiotic therapy in acute exacerbations of chronic bronchitis: Part 1. The rationale. Pulm Perspect. 2002;19:6–8.Google Scholar
  168. 168.
    Adams SG, Anzueto A. Antibiotic therapy in acute exacerbations of chronic bronchitis: Part 2. Pul Perspect. 2002;19:1–5.Google Scholar

Copyright information

© Humana Press Inc. 2004

Authors and Affiliations

  • Fernando J. Martinez
    • 1
  1. 1.Division of Pulmonary and Critical Care Medicine Department of Internal MedicineUniversity of Michigan Medical SchoolAnn Arbor

Personalised recommendations